Update on the Safety and Efficacy of Oral Anticoagulation in CKD and ESRD
Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) may have greater risk for atrial fibrillation, stroke/systemic embolism, and bleeding, so the net benefit of anticoagulation is controversial. Update on the Safety and Efficacy of Oral Anticoagulation in CKD and ESRD
Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) may have greater risk for atrial fibrillation, stroke/systemic embolism, and bleeding, so the net benefit of anticoagulation is controversial.
Metformin Reduces Death Risk in COVID-19 Patients With Diabetes
Metformin use among individuals with type 2 diabetes prior to a COVID-19 diagnosis was associated with a threefold decrease in mortality, according to a recent clinical study.
Opioid-Use Policies Causing Unintended Consequences
Measures instituted to stem a steep rise in overdose deaths may have unintentionally caused those with opioid-use disorders to switch to alternative illicit substances.Age Affects Gender-Related Heart Attack
Clinical news developments related to cardiology and cardiovascular disease.
Watch New
Pharmacist Recommendation Series here
Continuing Education
$6.97 Per CE Exam or $59 for 12 Lessons
-
Pain Management • April 2023 • 2.00 Credits
Osteoarthritis 2019 Guideline Updates and Best Practices
-
• March 2023 • 2.00 Credits
Evidence-Based Management of Nonspecific Low Back Pain in Adults
-
Women's Health, Pregnancy, Cardiovascular • February 2023 • 2.00 Credits
Review of Hypertension in Pregnancy for Pharmacists
Quick Poll
Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.